| Announce Date | 01/21/2026 |
| EPS Normalized Actual | $2.72 (Beat by $0.17) |
| EPS GAAP Actual | $2.72 (Beat by $0.17) |
| Revenue Actual | $4.669B |
| Revenue Surprise | Beat by $4669M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2029 | 15.5 | 13.93 | 14.83876 | 16.33531 | 1 |
| Sep 2029 | 15.55 | 13.88 | 15.03862 | 16.23346 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.55 | 2.55 | 4.669B | 17.84% | 4669M |
| FQ3 2025 (Sep 2025) | 2.25 | 2.25 | 4.749B | 14.34% | 4749M |
| FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 4.534B | 12.24% | 4534M |
| FQ1 2025 (Mar 2025) | 6.19 | 6.19 | 4.143B | 4.25% | 4143M |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 3.836B | 0.13% | 3836M |
| FQ3 2024 (Sep 2024) | 3.43 | 3.43 | 4.068B | 0.81% | 4068M |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 3.979B | -0.48% | 3979M |
| FQ1 2024 (Mar 2024) | 1.76 | 1.76 | 3.967B | 100% | 3967M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 3.12826 | -- | 3.02276 | 3.20492 | 8 |
| FQ1 2028 (Mar 2028) | 3.03713 | -- | 2.93471 | 3.11156 | 5 |
| FQ4 2027 (Dec 2027) | 2.84651 | -- | 2.75051 | 2.91626 | 3 |
| FQ3 2027 (Sep 2027) | 2.59758 | -- | 2.5721 | 2.66437 | 9 |
| FQ2 2027 (Jun 2027) | 2.54206 | -- | 2.51712 | 2.60742 | 9 |
| FQ1 2027 (Mar 2027) | 2.37268 | -- | 2.3494 | 2.43368 | 9 |
| FQ4 2026 (Dec 2026) | 2.69838 | 5.5 | 2.60738 | 2.7645 | 3 |
| FQ3 2026 (Sep 2026) | 2.36583 | 4.9 | 2.34262 | 2.42666 | 5 |
| FQ2 2026 (Jun 2026) | 2.3447 | 7.88 | 2.30474 | 2.40063 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 5.32B | -- | 5.18B | 5.42B | 3 |
| FQ1 2028 (Mar 2028) | 5.19B | -- | 5.06B | 5.29B | 5 |
| FQ4 2027 (Dec 2027) | 4.92B | -- | 4.79B | 5.01B | 4 |
| FQ3 2027 (Sep 2027) | 4.91B | -- | 4.87B | 5.01B | 6 |
| FQ2 2027 (Jun 2027) | 4.77B | -- | 4.74B | 4.87B | 6 |
| FQ1 2027 (Mar 2027) | 4.59B | -- | 4.56B | 4.69B | 6 |
| FQ4 2026 (Dec 2026) | 4.74B | 1.55 | 4.62B | 4.83B | 4 |
| FQ3 2026 (Sep 2026) | 4.56B | -4.24 | 4.52B | 4.65B | 6 |
| FQ2 2026 (Jun 2026) | 4.64B | 2.2 | 4.58B | 4.72B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.55 | 2.55 | 100% | |
| FQ3 2025 (Sep 2025) | 2.25 | 2.25 | 100% | |
| FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 100% | |
| FQ1 2025 (Mar 2025) | 6.19 | 6.19 | 100% | |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 100% | |
| FQ3 2024 (Sep 2024) | 3.43 | 3.43 | 100% | |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 100% | |
| FQ1 2024 (Mar 2024) | 1.76 | 1.76 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $4.67B | $4669M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $4.75B | $4749M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $4.53B | $4534M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $4.14B | $4143M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.84B | $3836M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.07B | $4068M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.98B | $3979M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.97B | $3967M | 100% |